series-c-plus
Stage
2003
Founded
2
Investors
About
AC Immune is a clinical-stage biopharmaceutical company discovering, designing and developing therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases with a focus on Alzheimer's disease.
Explore AC Immune's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.